Log In
BCIQ
Print this Print this
 

Fareston, toremifene citrate (formerly Acapodene)

  Manage Alerts
Collapse Summary General Information
Company Orion Corp.
DescriptionNon-steroidal selective estrogen receptor modulator (SERM)
Molecular Target Estrogen receptor 1 (ESR1)
Mechanism of ActionSelective estrogen receptor modulator (SERM)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer in postmenopausal women
Regulatory Designation
PartnerEisai Co. Ltd.;
Kyowa Hakko Kirin Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/25/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today